QQQS Stock: Invesco NASDAQ Future Gen 200 ETF Profile & Analysis (2026)
A targeted exchange-traded fund providing equal-weighted exposure to 200 innovative NASDAQ-listed small-cap companies selected based on patent value — Updated May 2026 with current AUM, expense ratio, holdings, and performance data.
The QQQS stock, formally known as the Invesco NASDAQ Future Gen 200 ETF, offers a unique lens into the next generation of innovators. Unlike the large-cap dominated TQQQ Stock Profile or its inverse counterpart SQQQ Stock Profile, QQQS focuses on the “completion cap” space. It specifically targets 200 companies listed on the NASDAQ that fall outside the top 200 by market capitalization, selecting them based on the strength and value of their intellectual property and patent portfolios.
This fund is heavily weighted toward the healthcare and technology sectors, often including small cap semiconductor stocks and emerging biotech firms. By utilizing an equal-weighted methodology, QQQS ensures that no single company dominates the fund’s performance, providing a diversified entry point into high-growth potential businesses that are often overlooked by traditional market-cap-weighted indexes.
Key Takeaways — QQQS Stock
Holdings are chosen based on the quality and value of their patent portfolios, identifying companies with significant intellectual property moats.
The fund maintains ~0.5% weighting for each of its 200 positions, reducing concentration risk and allowing smaller innovators to drive returns.
Nearly 83% of the fund is concentrated in Healthcare and Technology, sectors where patent protection is critical for long-term value.
By excluding the 200 largest NASDAQ stocks, it complements tech-heavy portfolios by capturing the “Future Gen” of growth stocks.
QQQS — Live Price Chart
Real-time chart from TradingView.
QQQS ETF Vitals & Key Statistics
Core data as of May 2026.
| Data Point | Value | Data Point | Value |
|---|---|---|---|
| Full Name | Invesco NASDAQ Future Gen 200 ETF | Ticker | QQQS |
| Issuer | Invesco | Asset Class | U.S. Equity Small Blend |
| Index Tracked | Nasdaq Innovators Completion Cap Index | Structure | ETF (Open-Ended) |
| Expense Ratio | 0.20% | AUM | ~$13.49M |
| Inception Date | October 13, 2022 | Exchange | nasdaq |
| No. of Holdings | 200-205 | Dividend Yield | 3.52% |
| 52-Week High | $37.53 | 52-Week Low | $19.55 |
| Avg Daily Volume | ~6,000 shares/day | YTD Return | 6.4% |
| 1-Year Return | 90.12% | 5-Year Return | 19.69% |
| Category | Small Blend | Dividend Frequency | Quarterly |
QQQS Top 10 Holdings (May 2026)
Largest positions by weight. Click columns to sort.
| Rank | Ticker | Company Name | Sector | Weight % |
|---|---|---|---|---|
| 1 | MRVL | Marvell Technology | Technology | 0.72% |
| 2 | HUBS | HubSpot | Technology | 0.68% |
| 3 | NU | Nu Holdings | Technology | 0.65% |
| 4 | PENG | Penguin Solutions | Technology | 0.63% |
| 5 | AEHR | Aehr Test Systems | Technology | 0.61% |
| 6 | CELC | Celcuity | Healthcare | 0.59% |
| 7 | PRAX | Praxis Precision Medicine | Healthcare | 0.58% |
| 8 | XMTR | Xometry | Industrials | 0.57% |
| 9 | BPMC | Blueprint Medicines | Healthcare | 0.55% |
| 10 | EXAS | Exact Sciences | Healthcare | 0.54% |
QQQS — Pros & Cons
✓ Innovation-Driven Growth
Focuses on companies with high-value patents, potentially identifying future market leaders before they reach large-cap status.
✗ Low Liquidity
With a low AUM of $13.49M and daily volume of 6k shares, it can be difficult to execute large trades without price impact.
✓ Sector Diversification
Provides a strong blend of biotech and hardware tech, offering a unique mix compared to the standard NASDAQ-100.
✗ High Volatility
Small-cap stocks and biotech firms are notoriously volatile, leading to wider price swings than broad market indexes.
✓ Competitive Pricing
At 0.20%, the expense ratio is relatively low for a specialized, intellectual-property-focused small-cap fund.
✗ Sector Concentration Risk
Extremely high exposure to Healthcare (~49%) means a downturn in biotech or regulatory changes could disproportionately affect the fund.
Who Should Consider QQQS?
Investors seeking small-cap growth with a focus on innovation and patents to complement a core large-cap portfolio.
Conservative investors or those requiring high liquidity for day trading; not suitable for those avoiding the healthcare sector.
You believe intellectual property is the primary driver of value in the modern economy and want equal-weighted exposure.
Tax-advantaged accounts (IRA/401k) to manage high turnover (~73%) or long-term taxable brokerage accounts.
QQQS vs Similar ETFs
Key metrics comparison.
| ETF | Full Name | Expense Ratio | AUM | Holdings | Div Yield | YTD | Best For |
|---|---|---|---|---|---|---|---|
| QQQS ★ | Invesco NASDAQ Future Gen 200 ETF | 0.20% | $13.49M | 200 | 3.52% | 6.4% | Innovation-focused small caps |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 0.15% | ~$750M | 100 | ~1.1% | ~12% | Mid-cap NASDAQ growth |
| QQQM | Invesco NASDAQ 100 ETF | 0.15% | ~$20B+ | 100 | ~0.6% | ~15% | Large-cap NASDAQ growth |
| QQQE | Direxion NASDAQ 100 Equal Weighted | 0.35% | ~$800M | 100 | ~0.8% | ~10% | Large-cap Equal Weight |
QQQS Technical Analysis
Real-time buy/sell signals.
QQQS — Risks & Considerations
Intellectual Property Risk
Patents can be challenged or become obsolete, meaning the fundamental selection criteria may not always lead to market outperformance.
High Turnover Costs
A 73% annual turnover rate leads to higher internal transaction costs and potential capital gains distributions.
Small-Cap Underperformance
Smaller companies can struggle during periods of high interest rates or economic contraction compared to blue chip stocks.
Regulatory Sensitivity
With nearly 50% in Healthcare, the fund is highly sensitive to FDA approvals, clinical trial results, and healthcare policy changes.